DNAVSIGR• 28 Days (Normalized)
DNA vs IGR (Ginkgo Bioworks Holdings Inc. vs CBRE Global Real Estate Income Fund Common Shares of Beneficial Interest)
Showing Closing Date Range from Aug 31 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+53.6%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
IGR Performance $12.05
+%
CBRE Global Real Estate Income Fund Common Shares of Beneficial Interest
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+53.6 pts
DNA outperforming by 53.60 percentage points
DNAIGR
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA IGR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | DNA Price | DNA Gain (%) | IGR Price | IGR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $10.46 | +53.60% | $- | - | |
| Sep 25, 2026 | $10.66 | +56.53% | $- | - | |
| Sep 24, 2026 | $10.25 | +50.51% | $- | - | |
| Sep 23, 2026 | $8.58 | +25.99% | $12.05 | +164.25% | -138.26% |
| Sep 22, 2026 | $9.37 | +37.59% | $- | - | |
| Sep 21, 2026 | $7.98 | +17.18% | $12.21 | +167.76% | -150.58% |
| Sep 18, 2026 | $7.88 | +15.71% | $12.35 | +170.83% | -155.12% |
| Sep 17, 2026 | $7.84 | +15.12% | $12.38 | +171.49% | -156.37% |
| Sep 16, 2026 | $7.06 | +3.67% | $12.30 | +169.74% | -166.07% |
| Sep 15, 2026 | $6.99 | +2.64% | $12.36 | +171.05% | -168.41% |
| Sep 14, 2026 | $7.01 | +2.94% | $12.60 | +176.32% | -173.38% |
| Sep 11, 2026 | $6.75 | -0.88% | $12.63 | +176.97% | -177.85% |
| Sep 10, 2026 | $6.78 | -0.44% | $12.54 | +175.00% | -175.44% |
| Sep 09, 2026 | $6.79 | -0.29% | $12.94 | +183.77% | -184.06% |
| Sep 08, 2026 | $6.94 | +1.91% | $- | - |
Page 1 of 2